NICE Key Therapeutic Topics – 2019 Update
Posted on:
NICE have updated and revised several Key Therapeutic Topic (KTT) documents and added two new topics to the KTT collection of evidence summaries to support medicines optimisation:
| KTT5 | Asthma: medicines safety priorities | UPDATE |
| KTT6 | Hypnotics | UPDATE |
| KTT7 | Antipsychotics in people living with dementia | UPDATE |
| KTT9 | Antimicrobial stewardship- prescribing antibiotics | UPDATE |
| KTT12 | Type 2 diabetes mellitus: medicines optimisation priorities | UPDATE |
| KTT14 | Wound care products | UPDATE |
| KTT17 | Acute kidney injury (AKI): use of medicines in people with or at increased risk of AKI | UPDATE |
| KTT18 | Multimorbidity and polypharmacy | UPDATE |
| KTT19 | Psychotropic medicines in people with learning disabilities whose behaviour challenges | UPDATE |
| KTT20 | Safer insulin prescribing | UPDATE |
| KTT21 | Medicines optimisation in chronic pain | UPDATE |
| KTT22 | Chemotherapy dose standardisation | UPDATE |
| KTT23 | Shared decision making | NEW |
| KTT24 | Suicide prevention: optimising medicines and reducing access to medicines as a means of suicide | NEW |